Fibrinogen and diabetes mellitus: is it time for intervention trials?
Ceriello
A
A
Department of Clinical and Experimental Pathology and Medicine, University of Udine, Italy.
D001161:Arteriosclerosis / Q000453:epidemiology* / Q000517:prevention & control*; D002986:Clinical Trials as Topic; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000503:physiopathology*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000503:physiopathology*; D003925:Diabetic Angiopathies / Q000453:epidemiology / Q000517:prevention & control*; D005340:Fibrinogen / Q000032:analysis / Q000502:physiology*; D006801:Humans; D008954:Models, Biological; D011237:Predictive Value of Tests; D012307:Risk Factors; D013917:Thrombin / Q000502:physiology
D005340:Fibrinogen; D013917:Thrombin